Maintenance of proliferative capacity and retroviral transduction efficiency of human fetal CD38(-)/CD34(++) stem cells

Stem Cells and Development
Marcus O MuenchAlicia Bárcena

Abstract

Methods for the efficient transduction and expansion of fetal hematopoietic stem cells could lead to novel in utero therapies for blood cell disorders and enzymatic deficiencies. Here we describe a new assay to measure rapidly the effects of cytokines on the differentiation or expansion of primitive progenitors and stem cells found among CD38(-)CD34(++) lineage() cells isolated from human midgestation liver. Importantly, conditions that otherwise supported the expansion of clonogenic progenitors reduced their proliferative capacity. A combination of megakaryocyte growth and development factor and granulocyte-macrophage colony-stimulating factor maintained proliferative potential while also yielding an intermediate level of progenitor expansion. Retroviral transduction was achieved using Moloney murine leukemia virus-based vectors. Freshly isolated candidate stem cells could be transduced at almost 17% efficiency by a 1-h exposure to virus with centrifugation to aid transduction. This was increased to a mean 35.5% transduction efficiency after 1 day of culture. Additionally, the transduction efficiency of candidate stem cells isolated from fetal placental blood was 33.0%. These findings encourage further investigation into the f...Continue Reading

References

May 1, 1990·International Journal of Cell Cloning·I K McNieceP J Quesenberry
Jul 1, 1994·British Journal of Haematology·B ThilaganathanG Morgan
Sep 1, 1993·The Journal of Experimental Medicine·P M LansdorpH Mayani
Dec 1, 1994·Leukemia & Lymphoma·M O MuenchM A Moore
Sep 1, 1996·Molecular Human Reproduction·A M DouarC Coutelle
Jun 3, 1998·American Journal of Obstetrics and Gynecology·L E Shields, R G Andrews
Sep 14, 1999·Bone Marrow Transplantation·F GolfierM Muench
Oct 16, 1999·Science·E D Zanjani, W F Anderson
Jan 12, 2000·Seminars in Perinatology·E Y YangN S Adzick
Feb 15, 2001·Fetal Diagnosis and Therapy·B W PaekM R Harrison
Feb 24, 2001·Human Reproduction Update·D V SurbekK H Nicolaides
Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·G S LipshutzK M Gaensler
Apr 21, 2001·Bone Marrow Transplantation·M O MuenchM R Harrison
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M O Muench, A Bárcena
Nov 8, 2002·Biochimica Et Biophysica Acta·Toshio Heike, Tatsutoshi Nakahata
Dec 12, 2002·Best Practice & Research. Clinical Obstetrics & Gynaecology·The-Hung BuiMagnus Nordenskjöld
Dec 3, 2003·Fetal Diagnosis and Therapy·Christopher D PoradaEsmail D Zanjani
Jun 12, 2004·Fetal Diagnosis and Therapy·Jean-Louis TouraineLucette Gebuhrer
Dec 8, 2004·Best Practice & Research. Clinical Obstetrics & Gynaecology·Alan W Flake
Jan 25, 2005·Bone Marrow Transplantation·M O Muench
Jan 26, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher D PoradaEsmail D Zanjani
Feb 1, 2005·European Journal of Immunology·Tom CupedoHergen Spits

❮ Previous
Next ❯

Citations

Jun 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·Lin YeYuet Wai Kan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.